<DOC>
	<DOCNO>NCT02645656</DOCNO>
	<brief_summary>Curcumin ( diferuloylmethane ) chief component spice turmeric derive rhizome East Indian plant Curcuma longa . Curcuma longais member Zingiberacae ( ginger ) family botanical perennial plant native Southeast Asia . Turmeric contain class compound know curcuminoids , comprise curcumin , demethoxy curcumin bisdemethoxycurcumin .</brief_summary>
	<brief_title>Topical Application Curcumin Orabase Oral Submucous Fibrosis ( OSMF )</brief_title>
	<detailed_description>Anti-inflammatory mechanism implicate anticarcinogenic potential curcumin include : ( 1 ) inhibition NF-ÎºB COX-2 ( increase level COX-2 associate many cancer type ) ; ( 2 ) inhibition arachidonic acid metabolism via lipoxygenase scavenge free radical generate pathway ; ( 3 ) decrease expression inflammatory cytokine IL-1b , IL-6 , TNF-a , result growth inhibition cancer cell line ; ( 4 ) down-regulation enzyme , protein kinase C , mediate inflammation tumor-cell proliferation . Curcumin 's potent anti-oxidant free-radical quenching property play important role inhibitory effect compound initial stage carcinogenesis . Antioxidants implicated pathogenesis OSMF hence preparation may helpful resolution lesion .</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Oral Submucous Fibrosis</mesh_term>
	<mesh_term>Curcumin</mesh_term>
	<criteria>Subjects show classic clinical sign OSMF intervention include . Subjects receive receive form therapy six month period lead study exclude .</criteria>
	<gender>All</gender>
	<minimum_age>22 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Oral Submucous Fibrosis</keyword>
	<keyword>Curcumin</keyword>
</DOC>